[Lymphogranuloma venereum, an STI that is sometimes recognized late in secondary care].

Autor: Bosma JW; OLVG, afd. Interne Geneeskunde, Amsterdam.; Contact: J. W. Bosma (j.w.bosma@amsterdamumc.nl)., van Tienhoven AJ; OLVG, afd. Interne Geneeskunde, Amsterdam., Thiesbrummel HFJ; OLVG,afd. Medische Microbiologie, Amsterdam., de Vries HJC; Amsterdam UMC, locatie AMC, afd. Dermatologie, Amsterdam., Veenstra J; OLVG, afd. Interne Geneeskunde, Amsterdam.
Jazyk: Dutch; Flemish
Zdroj: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2020 Nov 19; Vol. 164. Date of Electronic Publication: 2020 Nov 19.
Abstrakt: Lymphogranuloma venereum (LGV) is an invasive sexually transmitted infection caused by Chlamydia trachomatis genotypes L1, L2 and L3. Until recently, LGV was rarely seen in developed countries. However, an outbreak of LGV infections in Europe amongst men who have sex with men (MSM) has been reported in the past decades. Diagnosing LGV can be challenging since there is no pathognomic clinical presentation. Most patients are diagnosed with LGV by Community Healthcare Services and general practitioners. Recent data show that a significant diagnostic delay can occur when patients present in a hospital with symptoms due to LGV infection. This can result in unnecessary additional diagnostic procedures and a subsequent diagnostic delay. In order to create more awareness, we describe 3 cases in our hospital with an initially unrecognized LGV infection. We also discuss the epidemiology, clinical manifestations, diagnostic process and treatment of LGV infection.
Databáze: MEDLINE